Unaudited Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2020	Dec. 31, 2019
CURRENT ASSETS
Cash and cash equivalents	$ 10,030,024	$ 5,114,917
Trade and other receivables	19,014	21,064
Prepaid expenses	414,683	510,900
Total current assets	10,463,721	5,646,881
Property and equipment, net	31,130	41,036
Patents, net	649,745	668,936
ROU and other assets	215,953	227,036
Total assets	11,360,549	6,583,889
CURRENT LIABILITIES
Accounts payable and accrued expenses	961,026	824,406
Accrued bonuses	98,750	135,686
Short-term note and other current liabilities	126,450	264,665
Total current liabilities	1,186,226	1,224,757
Warrant liabilities, at fair value	59,971	84,596
Lease liability, net of current portion	136,395	148,543
Total liabilities	1,382,592	1,457,896
Commitments and contingencies (Note 5)
STOCKHOLDERS' EQUITY
Preferred stock, 7,000,000 shares authorized, $0.01 par value; 200,000 shares issued and outstanding at March 31, 2020 and December 31, 2019	2,000	2,000
Common stock, $0.01 par value; 300,000,000 shares authorized, 9,428,011 and 3,866,457 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively	94,280	38,665
Additional paid-in capital	239,439,587	227,067,058
Accumulated other comprehensive loss	(7,148)	(6,186)
Accumulated deficit	(229,550,762)	(221,975,544)
Total stockholders' equity	9,977,957	5,125,993
Total liabilities and stockholders' equity	$ 11,360,549	$ 6,583,889